Venous Thromboembolic Disease

Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

Observational Prospectif Monocentric Registry of Patients Suffering From VIE

Cohort for Monitoring Patients With Venous Thromboembolic Disease

Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study

THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy

Association Between Genetic Variant Scores and Warfarin Effect

Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients

Clotting Parameters After Medical Abortion

Screening for Cancer in Patients With Unprovoked VTE

Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin

CHIPs-VTE Study in Hospitalized Patients With Lung Cancer

Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data

Predictors of Attempted Inferior Vena Cava Filters Retrieval.